Form EFFECT Quoin Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 3, 2025 |
| Accession Number: | 0001104659-25-029406 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LiberNovo Support Week Is Live With Up to 37% Off and Tiered Gifts Across Its 2026 Chair Lineup
- The Boulder Group Arranges Sale of Huntington Bank in Chicago MSA
- Wolters Kluwer and Dentsu Soken Deliver CCH® Tagetik as Daihatsu Motor’s Budget Management System
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
